Pivotal Study to Evaluate the Safety and Efficacy of GelrinC for Treatment of Cartilage Defects

Status unconfirmed · Not applicable

Conditions studied: Articular Cartilage Defects in the Knee Joint

In brief

Multicenter, open-label, controlled, non-randomized, double arm trial with a prospective treatment arm (GelrinC). This study compares the efficacy and safety of GelrinC to a historical control arm (microfracture) in the treatment of cartilage defects in the knee.

Key facts

Study ID

NCT03262909

Run by

Regentis Biomaterials

People needed

181

Starts

2017-11-14

Expected to finish

2024-11-01

Last updated by the study team

2022-03-22

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Horizon Clinical Research — La Mesa, California, United States
• Hoag Orthopedics — Orange, California, United States
• University of Colorado — Denver, Colorado, United States
• Shrock Clinical Research — Fort Lauderdale, Florida, United States
• Andrews Institute — Gulf Breeze, Florida, United States
• Jewett Orthopaedic Clinic — Orlando, Florida, United States
• Optim Orthopedics — Savannah, Georgia, United States
• Midwest Orthopaedics at Rush — Chicago, Illinois, United States
• Peninsula Orthopaedic Associates — Salisbury, Maryland, United States
• Tria Institute — Bloomington, Minnesota, United States
• Alpine Orthopedics — Bozeman, Montana, United States
• University Orthopedics Center — Altoona, Pennsylvania, United States
• Mansfield Orthopedics — Morrisville, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.